glyphosphine has been researched along with Diabetes Mellitus, Type 1 in 1 studies
*Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atkinson, MA; Eisenbarth, GS; Fuse, M; Gottlieb, PA; McDaniel, K; Michels, AW; Nakayama, M; Ostrov, DA; Roep, BO; Zhang, L | 1 |
1 other study(ies) available for glyphosphine and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Structure-based selection of small molecules to alter allele-specific MHC class II antigen presentation.
Topics: Alleles; Animals; Antigen Presentation; Autoantigens; Diabetes Mellitus, Type 1; Enzyme-Linked Immunosorbent Assay; Glycine; Histocompatibility Antigens Class II; Humans; Insulin; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred NOD; Models, Molecular; Organophosphorus Compounds; Peptide Fragments; Receptors, Antigen, T-Cell; Small Molecule Libraries; Structure-Activity Relationship | 2011 |